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Background: Diabetes mellitus induces chronic complications such as cardiovascular damage, cataracts and
retinopathy, nephropathy, and polyneuropathy. The main aim of the study was to isolate and identify both of
bacterial strain and exopolysaccharide to assess the possible efficiency of exopolysaccharide (BSEPS) from Bacillus
subtilus sp .suppress on cardiovascular diseases, atherogenic and coronary risk indices in diabetic rats.
Methods: The bacterial strain used was isolated from mangrove tree sediment by serial dilution and the spread-
plate technique and identified by morphological, physiological, and biochemical characteristics, and by 16S rRNA
analysis. The BSEPS was extracted from the bacterial supernatant by four volumes child ethanol then the functional
groups, MW and chemical analysis were detected by Fourier-transform infrared (FTIR), gel permeation
chromatograph (GPC) and High-performance liquid chromatography (HPLC). Also an antioxidant activity was
measured by using 2,2-diphenyl-1-picrylhydrazyl (DPPH). Thirty-two male Sprague–Dawley rats were equally
randomized into four groups: control group supplemented with normal saline (Group I); the second group
supplemented with BSEPS (Group II); diabetic group supplemented with normal saline (Group III) and the diabetic
group supplemented with BSEPS (Group IV). Diabetes was induced by Streptozotocin (STZ) (65 mg/kg BW)
intraperitoneally. BSEPS (100 mg/kg BW) was administered orally for four weeks, following STZ induction.
Results: The isolated strain was identified based on 16S rRNA sequence as Bacillus subtilis sp. suppress. A preliminary
chemical analysis of BSEPS indicated that the monosaccharides were mannuronic acid, glucuronic acid, glucose,
galactose, and mannose in a molar ratio of 1.6:1.5:1.0:2.3:1.4, respectively, with a molecular weight of 1.66 ×
104 g mol−1 and a molecular number of 7.64 × 103 g mol−1. BSEPS inhibited 2,2-diphenyl-1-picrylhydrazyl radical
activity, and BSEPS supplement reduced glucose (p < 0.05) and troponin levels while insulin levels increased (p <
0.05). BSEPS also reduced total serum cholesterol, low-density lipoprotein (LDL), very low-density lipoprotein (VLDL),
and triglycerides, and elevated high-density lipoprotein-cholesterol (HDL). In parallel, intercellular adhesion molecule
(ICAM), and vascular cell adhesion molecule (VCAM) levels in STZ-induced diabetic rats were reduced. Moreover,
polysaccharides reduced atherogenic and coronary risk indices, which were confirmed by histopathological
examination of the heart and aorta.
Conclusions: Our study suggests that BSEPS improves hyperglycemia, dyslipidemia, and cardiovascular disease risk
in STZ-induced diabetic rats.
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Diabetes mellitus is a heterogeneous combination of
chronic perturbations of carbohydrate, lipid, and protein
metabolism characterized by increased blood glucose
owing to partial or absolute insulin deficiency [1]. The
World Health Organization estimates that diabetes af-
fects 285 million people globally, and current predictions
estimate that 438 million people will be diabetic by 2030
[2, 3]. Pharmacological treatment of diabetes relies on
oral hypoglycemic agents and insulin, but these ap-
proaches currently used in clinical practice either do not
restore normal glycemic levels in most patients or their
levels change over time. Moreover, continuous use of
synthetic anti-diabetic drugs causes side effects and tox-
icity [4]. Because of the limitations and unmet goals as-
sociated with anti-diabetic drugs, an increased number
of diabetic patients globally currently resort to comple-
mentary and alternative medicine [5]. Therefore, natural
and non-toxic anti-diabetic drugs are inevitable for dia-
betic therapeutics such as exopolysaccharides (EPSs) [6].
Metabolic abnormalities and oxidizing stress arise at
early stages of diabetes and are significant risk factors
for complications of the nervous, cardiovascular, excre-
tory, and reproductive systems [7]. Several remedial
agents are effective for hyper-cholesterolemic patients
and are used successfully for treatment. A variety of
studies have demonstrated that the mechanism of lipid-
lowering drugs can reduce the number of cardiovascular
events and mortality from coronary disease [8]. EPSs are
natural macromolecules present throughout the growth
of many microorganisms. An inordinate number of bac-
terial EPSs has attracted the interest of many scientists
who have examined their composition, structure, biosyn-
thesis, and functional properties [9]. A number of re-
ports have been published on the anti-atherosclerosis
effect of acidic EPSs and the inhibition of total choles-
terol [10]. Atherosclerosis is combined with a broad
spectrum of cardio-metabolic disturbances, including
diabetes, arteriosclerosis, and cardiovascular disease. Ba-
cillus sp. is one of the marine bacteria that produce
complex homo-and/or heteropolysaccharides. Bacillus
sp. produce a variety of EPSs such as levan [11] and β-
(1–3)-glucan [12], and hetero-polymers composed
mainly of neutral sugar [13], uronic acid [14], uncom-
mon sugar [15], or sugar protein conjugates [16]. The
form and mechanisms of the pharmaceutical effects of
medical specialty EPSs on diseases have been largely elu-
cidated, and normal EPSs with different curative poten-
tial have been studied and even included in therapies.
Thus, the present study was designed to evaluate the
potential beneficial effect of the exopolysaccharides
(BSEPS) from Bacillus subtilus sp. suppress from marine
on serum lipid parameters and cardiovascular disease
risk predictor in normal and Streptozotocin-induceddiabetic rats. Additionally, the chemical structure of
purified BSEPS was elucidated after identification of iso-
lated bacterial strain.
Methods
I- In vitro study
Screening and identification
Marine sediment collected from the mangrove tree (El-
Ein El-Sokhna, Egypt) was suspended in 90 mL sterile
water. Serial dilution and the spread-plate technique
were used for growing different bacteria. The screening
medium contained (all reagents in g/L) glucose 20; yeast
extract 0.1; CaCO3 1; NH4NO3 0.8; K2HPO4 0.6;
KH2PO4 0.5; MgSO4.7H2O 0.05, and MnSO4.4H2O 0.1
in 75 % sea water [17]. The initial screening selected for
smooth, ropy, and mucous colonies from each plate,
with subcultures maintained on marine nutrient agar
medium until a pure isolate was obtained. Pure colonies
were then inoculated into 50 mL of marine nutrient
medium in a 250-mL conical flask, and incubated at 37 °C
in a rotary shaker at 120 rpm for 48 h. After centrifuga-
tion, supernatant was mixed with four volumes of chilled
ethanol. The precipitate was collected by centrifugation
and the pellets washed by acetone and diethyl ether, and
dried at 50 °C until constant weight. EPS production was
determined by the phenol-sulfuric acid method [18].
Strain NRC-108, which produces elevated EPS levels, was
identified on the basis of morphological, physiological,
and biochemical characteristics [19] combined with 16S
rRNA sequence analysis. The universal primers delin-
eated by Weisburg et al. [20], particularly ITS1 and
ITS4, were used to amplify the 16S rRNA gene se-
quence. A single, discrete, polymerase chain reaction
amplicon was resolved on agarose. Sequencing prod-
ucts were resolved on an Applied Biosystems (Foster
City, CA, USA) model 3730 XL, automated DNA se-
quencing system. Data were submitted to GenBank and
the sequence compared with the GenBank database
(http://www.ncbi.nlm.nih.gov) using BLAST [21].
Isolation and purification of EPSs
Inoculums was prepared by transferring one loop full of
culture (NRC-108) from marine nutrient slant to an
Erlenmeyer flask (250 mL) consisted of 50 ml seed
medium, (g/L) sucrose 20; yeast extract 2; peptone and
75 % sea water [22]. The seed cultures were grown at
37 °C on a rotary shaker incubator at 150 rpm for 24 h.
After incubation, 3 ml of the seed culture was trans-
ferred into an Erlenmeyer flask (250-mL) containing
50 ml of fermentation medium (g/L) sucrose 50; peptone
4; yeast extract 2 in 75 % sea water pH 7.0 [23]. The fer-
mentation cultures were then incubated at 37 °C with
shaking at 150 rpm for 3 days. The fermented broth was
collected and centrifuged at 3500 xg at 4 °C for 30 min
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tap-water using dialysis tubing (MWCO 2000) for 48 h.
The dialyzed solution through precipitation with four
volumes chilled ethanol, the precipitate washed with
acetone, diethyl ether and dried at 40 °C until constant
weight. The crude EPS was re-dissolved in deionizaed
water and forced through a filter (0.45 mm), then ap-
plied to a column (2.5 × 70 cm, i.d.) of DEAE-cellulose.
After loading with a sample, the column was eluted with
a gradient NaCl solution (0.0–1.0 M), and the procedure
was monitored by the phenol-H2SO4 method mentioned
above. One polysaccharide active fraction (BSEPS) was
collected, dialyzed and lyophilized. BSEPS was used for
activity assessment and structural analysis [24].
Chemical analyses
Purified BSEPS (50 mg) was subjected to hydrolysis with
6 N HCl for 4 h at 100 °C in a sealed tube. Excess acid
was removed by evaporation on a water bath at 40 °C
and co-distilled with water (1 mL × 3) [25]. Uronic acid
content was determined by measuring the absorbance
at 525 nm using the m-hydroxybiphenyl colorimetric
procedure and with glucuronic acid as the standard
[26]. Sulfate was measured using the turbidimetric
method [27] with sodium sulfate as the standard. N-
acetylglucosamine was estimated by the Morgan and
Elson reaction [28]. Ultraviolet–visible (UV–vis) spec-
troscopy analyses were conducted on a UV–vis spectro-
photometer (2401PC; Shimadzu, Kyoto, Japan). BSEPS
solution was prepared by suspending the sample in dis-
tilled water to 1.0 mg/mL for UV–vis measurement at
190–700 nm. BSEPS monosaccharide composition was
determined by High Performance Liquid Chromatog-
raphy (HPLC) on a Shimadzu Shim-Pack SCR-101 N
column (7.9 mm × 30 cm, i.d.), using deionized water as
the mobile phase (flow rate 0.5 mL/min), as described
by El-Sayed et al. [29].
Fourier-transform infrared spectroscopy
The Fourier-transform infrared spectrum of BSEPS
was measured on a Bruker 500-IR Spectrophotometer
(Billerica, MA, USA). The sample was mixed with KBr
powder, ground, and pressed into 1-mm pellets for
Fourier-transform infrared measurements in the range
of 400–4000 cm−1 [30].
Molecular-weight determination
BSEPS molecular weight was determined on an Agilent
1100 HPLC system equipped with a refractive index de-
tector and FPl gel particle (5 μm), three columns of pore
type (100, 104, and 105 A°) in series, length 7.5 ×
300 mm (1000, 5000000) for DMF solvent Styrogel HR-
DMF, 3 μm (7.8 × 300 mm) (Waters, Milford, MA,
USA). One column (5000–600,000) was used for watersolvent (polyethylene oxide/glycol standard) PL aquagel,
OH 7.5 mm and 30 μm pore, 8 um particle size. Sample
(0.01 g) was dissolved in 2 mL of solvent and filtrated
(0.45 mm) and transferred to a gel-permeation chroma-
tography (GPC) device [31]. Number average molecular
weight (Mn) and number average molecular weight
(Mw) were directly calculated according to the definition
of Mn and Mw using molecular weight and refractive
index signal values at each elution volume [32].
BSEPS scavenging activity of DPPH free radicals
BSEPS free radical scavenging activity was measured
against DPPH radicals using the method of Asker et al.
[33]. DPPH ethanol solution (5 mL, freshly prepared)
was added to 1 mL of BSEPS solution (30, 50, 70, and
100 μg mL−1). Solutions were mixed vigorously and in-
cubated at room temperature in the dark for 30, 60, 90,
and 120 min. Supernatant absorbance was measured at
517 nm. A lower absorbance indicates higher free radical
scavenging activity, as determined from graphing inhib-
ition percentage plotted against compound concentra-
tion. All experiments were carried out in triplicate and
averaged. The ability to scavenge DPPH radicals was cal-
culated using the following equation:
Scavenging ability %ð Þ ¼ ½ OD517of control– OD517of sample
 
=OD517of control  100
II- In vivo study
Animals
Thirty-two male Sprague–Dawley rats (180–200 g) were
used in this study. Rats were purchased from the labora-
tory animal colony of the Egyptian Organization for
Biological Products and Vaccines (VACSERA) (Helwan,
Cairo, Egypt). The animals were housed in the Animal
House of the Radioisotopes Department, Atomic Energy
Authority, Egypt, under hygienic conditions and fed for
1 week on a basal diet for adaptation and supplied with
water ad libitum. The Animal Care Committee of the
National Centre for Radiation Research and Technology,
Cairo, Egypt, approved the treatment protocol, following
the guidelines of the National Institutes of Health.
Induction of diabetes in experimental rats
Diabetes was induced by a single intraperitoneal injec-
tion of a freshly buffered (0.02 M citrate, pH 4.5) solu-
tion of STZ (Sigma Chemical Co., St. Louis, MO, USA)
at a dosage of 65 mg/kg body weight, as described previ-
ously [34]. After 72 h of STZ administration, tail vein
blood was collected to determine fasting blood glucose
levels. Rats with fasting blood glucose ≥200 mg/dL were
considered diabetic and included in the experiments
[35]. Treatment with EPS was after the last STZ
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study (30 days).
Acute toxicity (LD50) test for BSEPS
Acute toxicity (LD50) was determined for 18 rats in two
phases using the method of Lorke [36]. In the initial
phase, the rats were divided into three groups of three
rats each. They were orally treated with 10, 100, and
1000 mg/kg of extract and observed for 24 h for mortal-
ity. In the second phase, rats were grouped into three
groups of three rats each and orally treated with the ex-
tract at varying doses (1600, 2900, and 5000 mg/kg).
Rats were observed for 24 h and the final LD50 value
was determined from the minimum concentration
(death) and maximum concentration (survival) of the
dose as follows:
LD50 ¼ M0 þ M1ð Þ=2;
where M0 is the highest dose of test substance with
survival and M1 is the lowest dose of test substance
resulting in death.
Experimental design
After 1 week of adaptation, rats were divided into four
groups of eight rats each as follows: Group I served as a
negative control (a single intraperitoneal injection of
freshly buffered [0.02 M citrate, pH 4.5] without STZ)
[34]. Rats were injected with normal saline (0.5 mL, or-
ally) 3 days later and every other day for 30 days. Group
II was administered normal BSEPS (100 mg/kg BW) dis-
solved in saline. Group III was given STZ (65 mg/kg
BW) dissolved in citrate buffer (pH 4.5) and injected in-
traperitoneally within 10 min after preparation. Rats
were administered with normal saline (0.5 mL, orally)
3 days later and every other day for 30 days. Group IV
consisted of diabetic rats who received daily BSEPS or-
ally, for 30 days. Normal groups were provided common
commercial rat chow. Diabetes was confirmed after
72 h of STZ injection. Blood samples were collected
through the caudal vein and blood glucose levels esti-
mated by diagnostic kits. Rats having blood glucose
levels more than or equal to 200 mg/dL were selected
and used for the study.
Biochemical analysis
At the end of the experiment animals were fasted over-
night, anesthetized, and sacrificed to obtain blood sam-
ples. Each blood sample was placed in a dry clean
centrifuge tube, and centrifuged for 10 min at 2100 xg
to separate the serum. Serum was carefully separated
into clean dry Wassermann tubes using a Pasteur pipette
and kept at −80 °C until analysis.Serum glucose level (mg/dL) was determined using a
glucose test kit (Egy-Chem, Cairo, Egypt) based on the
Trinder et al. glucose oxidase method [37]. Insulin levels
were determined by radioimmunoassay according to
Clark et al. [38]. Troponin T levels were determined by
means of a third-generation troponin T assay (Elecsys;
Roche Diagnostics, Indianapolis, IN, USA) that uses re-
combinant cardiac troponin T as a standard [39]. Trigly-
ceride was determined by the method suggested by
Trinder et al. [40]. Total cholesterol was estimated by
the method described by Roeschlau et al. [41]. HDL-C
and LDL-C were measured using the method described
by Assman et al. [42] and VLDL-C was measured using
the formula Triglyceride/5 = VLDL-C (mg/100 mL).
Atherogenic index
The atherogenic index (AI) was determined by the formula
suggested by Haglund et al. [43]. Briefly, AI = (TC-HDL)/
HDL and coronary heart index (CRI) was calculated as de-
scribed by Ishiguro et al. using the formula: CRI = Total
cholesterol/HDL-cholesterol [44].
Molecular markers of atherosclerosis and coronary heart
disease
VCAM-1 and ICAM-1 serve as molecular markers of
atherosclerosis and predictors of incident coronary heart
disease, respectively. ICAM-1 and VCAM-1 levels were
determined using Duo Set ELISA kits (R&D Systems,
Minneapolis, MN, USA), in 96-well plates following the
manufacturer’s protocol. Absorbance was measured at
450 ± 10 nm with a Stat Fax 2100 Microplate Reader
(MidSci, St. Louis, MO, USA). Levels of VCAM-1 and
ICAM-1 were normalized using the total cellular protein
concentration, which is proportional to cell number.
Histological examination
Autopsy samples were taken from the aorta and fixed in
10 % formal saline for 24 h, washed in tap water, then
dehydrated in serial dilutions of alcohol (methyl, ethyl,
and absolute ethyl). Specimens were cleared in xylene
and embedded in paraffin at 56 °C in a hot air oven for
24 h. Paraffin bees wax tissue blocks were prepared for
sectioning at 4 microns (μm) thickness by Sledge Micro-
tome (Leica Biosystems Inc., Buffalo Grove, IL, USA).
Tissue sections were collected on glass slides, deparaffi-
nized, and stained by hematoxylin and eosin stain for
examination by light microscopy [45].
Statistical analysis
Data analysis was carried out with SPSS Inc. software
V22 (IBM, Chicago, IL, USA). One-way analysis of vari-
ance was used to determine statistically significant differ-
ences between dietary groups (P < 0.05). Duncan’s test
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data are presented as ± standard error of the mean.
Results
Screening and strain identification
EPSs from different strains may be different in yield,
chemical composition, structure, and physical properties.
Forty-two bacterial isolates were isolated from soil sam-
ples, with 19 isolates obtained based on the carbohydrate
content of their supernatant broth. Although most isolates
produced EPS, strain NRC-108 was selected for further
study because it demonstrated the highest EPS production
(9 g/L). NRC-108 colonies exhibited a creamy mucous on
solid medium, and were Gram-positive, rod shaped, and
spore forming. The strain produced amylase and arginine
and was negative for nitrate reduction, positive for Voges-
Proskauer and indol tests, and acid production. Hence,
strain NRC-108 was tentatively identified as Bacillus sp.
Comparison of 16S rRNA gene sequence among NRC-
108 and other bacteria from GenBank by BLAST analysis
showed the closest strains (99 % similarity) were B. subti-
lis, B. licheniformis DSM13, and B. pumilus SAFR-032.
Phylogenetic analysis results indicated that NRC-108 was
most closely related to B. subtilis (Fig. 1). The strain is
therefore identified as B. subtilus sp. suppress.
Production and isolation of BSEPS
NRC-108 produced high levels of EPS (10.5 g/L) when
fermented at 35 °C for 96 h, as determined by theFig. 1 Phylogenetic neighbor joining tree obtained with the 16S rDNA seqphenol–sulfuric acid assay using glucose as a standard.
Crude EPS was obtained from fermented broth by etha-
nol precipitation and dehydration by acetone and di-
ethyl ether. The crude EPS was fractionated on a
DEAE-cellulose anion exchange chromatography col-
umn (Fig. 2). One major EPS peak was eluted with
0.3 M NaCl, concentrated, dialyzed, and lyophilized to
obtain purified BSEPS (white-yellow powder), which
was used for subsequent analyses. It produced a posi-
tive response to the Bradford test and absorption at
280/260 nm, indicating the presence of protein and/or
nucleic acid. UV–vis spectroscopy analysis showed that
the maximum absorption was 200–220 nm owing to
n–σ* and/or π-π* transitions, characteristic of amine
functional groups.
The largest absorbance peak at 210 nm is characteris-
tic of BSEPS. There was weekly absorption at 280 nm,
indicating very small amounts of protein. BSEPS also
contained 35.4 % uronic acid as evaluated by m-
hydroxydiphenyl colorimetry, 4.9 % sulfate, and 4.1 % N-
acetyl glucose amine. The BSEPS FT-IR spectrum (Fig. 3)
displayed a strong band at 3410.49 cm−1, attributed to poly-
saccharide O-H stretching vibration. The 2927.41 cm−1
band was due to C–H stretching vibration. A symmetrical
stretched peak near 1388.50 cm−1 indicated the pres-
ence of carboxyl groups. The prominent absorption at
1633.41 cm−1 was attributed to C = O and C-N stretch-
ing vibrations, whereas absorption at 1132.97 cm−1 was
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Fig. 2 Elution curve of BSEPS from Bacillus subtilis sp. over DEAE-
cellulose column. The absorbance at 490 nm was that of the resulting
reactive solutions of exopolysaccharides, phenol and sulfuric acid
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suggest that α-configurations were simultaneously present
in BSEPS [46].
The BSEPS chemical structure was analyzed by HPLC
and compared with monosaccharide standards. BSEPS
was composed of mannuronic acid, glucuronic acid,
glucose, galactose, and mannose in a molar ratio of
1.6:1.5:1.0:2.3:1.4, respectively (Fig. 4). EPSs from mar-
ine bacteria are primarily heteropolysaccharides con-
sisting of pentoses, hexoses, amino sugars, or uronic
acids arranged in repeating units. In order to the chem-
ical composition determines position; so, the EPSs con-
tain galactose and mannose that form an unstirredFig. 3 IR spectrum of the BSEPS from Bacillus subtilis sp. in the range 400–4water layer in the gut, which decreases absorption of
sugars and lipids. This effect is a property of EPS struc-
ture that, by decreasing the rate of gastric emptying,
and resisting the convective effects of intestinal con-
tractions, decreases sugar absorption by the small intes-
tine. Thus, to some extent, soluble fibers can be used to
prevent the postprandial increase of glucose, making it
useful for the treatment of diabetes [47]. EPSs from
marine bacteria usually possess hydroxyl and carboxyl
groups, which confer a net negative charge and acidic
properties. BSEPS molecular weight was calculated for
the portions of peaks that lie within the peak ranges.
BSEPS Mw was determined to be 1.66 × 104 g mol−1
and the Mn to be 7.64 × 103 g mol−1. The polydispersity
index (Mw/Mn) is a measure of the width of molecular-
weight distribution 2.17 (Fig. 5).
Most marine EPSs are linear overall and of varying
lengths, with a mean molecular mass of 1 × 105–3 ×
105 Da. Organic or inorganic substitutes may also be
present [48]. In recent years, there have been reports of
deep sea hydrothermal bacteria secreting EPSs; they are
typically acidic and contain uronic acid (10–40 %) and a
large molecular weight of up to 1 × 106 g mol−1 [49].
The hypotriglyceridemic effect might be owing to a de-
layed absorption of triglyceride in the small intestine
caused by the high viscosity of the intestinal contents
[50]. Therefore, the viscous structure and molecular
weight of polysaccharides are thought to be important
for limiting absorption in the digestive tract, and in-
creasing cholesterol excretion [50].000 cm−1
Fig. 4 HPLC chromatogram profile of BSEPS hydrolysate
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BSEPS was found to significantly inhibit the activity of
DPPH radicals in a dose-dependent manner at concen-
trations from 30 to 100 μg/mL [32, 33]. Additional
BSEPS (100 μg/mL) lead to increased viscosity and tur-
bidity, prompting us to stop treatment.
Serum glucose and troponin levels increased (p < 0.05),














Fig. 5 Weight average molecular weight (Mw) and number average moleculinduced diabetic rats compared with controls (Table 1).
EPS supplementation reduced serum glucose and tropo-
nin T levels and increased insulin levels (p < 0.05) in the
STZ-induced diabetic rats (Group IV).
Serum lipid profile
The present results noted an increase in serum total
cholesterol, triglyceride, LDL-cholesterol, and VLDL-r mass [D]























ar weight (Mn) distributions of BSEPS production by Bacillus subtilis sp
Table 1 Effect of treatment with polysaccharide on glucose, insulin and troponin concentrations in control, and STZ-induced dia-
betic rats
Groups Group I Group II Group III Group IV F P-value
Glucose (mg/dl) 78.48 ± 7.37b 83.60 ± 2.99b 206.50 ± 6.24a 82.70 ± 3.08b 140* 0.000
Insulin (μIU/mL) 31.38 ± 1.24a 30.47 ± 2.33a 11.56 ± 1.67b 27.34 ± 0.99a 31.87* 0.000
Troponin-T(pg/mL) 31.43 ± 3.14b 33.50 ± 2.53b 47.27 ± 2.18a 34.65 ± 2.59b 7.40* 0.005
Data expressed as mean ± SE
a,bThe groups in the same raw with different letters are statistically significant (*P < 0.05) using one-way ANOVA followed by Duncan as a post-hoc test
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creased HDL-cholesterol levels compared with normal
rats (p < 0.05) (Table 2). Interestingly, BSEPS treatment
of STZ rats decreased serum lipid profiles (total choles-
terol, LDL-cholesterol, VLDL-cholesterol, and triglycer-
ides) (p < 0.05) and increased HDL (p < 0.05).
AI, CRI, VCAM, and ICAM
STZ control rats exhibited a profound increase in AI
compared with normal rats (Table 3), suggesting that
BSEPS treatment decreases AI. Similarly, VCAM and
ICAM levels increased in the diabetic group compared
with controls, while STZ-induced diabetic rats treated
with EPS typically improved, with parameters returning
to control levels. Similarly, the data indicate that STZ in-
creases the CRI compared with normal rats (8.90 ± 0.56
vs. 1.6 ± 0.19). In addition, BSEPS-treated rats exhibited
an improved CRI (1.51 ± 0.09), compared with diabetic
rats. The acute toxicity data indicate the LD50 was
600 mg/kg, which implies that at this concentration,
50 % of the animals would be killed (Table 4).
Histopathological findings
We did not observe any major histological differences
between groups GI and GII in either the heart tissues or
the aorta, by hematoxylin and eosin staining (Fig. 6a–d).
In STZ rats beginning on the 4th week, focal hemor-
rhages, congestion, perivascular edema in the small
intramuscular arterioles, and focal muscular hyaliniza-
tion were consistently observed in the heart (Fig. 6e).
The focal area in the degenerated myocardium displayed
myo-fibroblast proliferation with a little infiltration of
inflammatory cells, as well as congestion in the blood
vessels of GIII rats (Fig. 6e). There was also edema inTable 2 Effect of treatment with polysaccharide on lipid profile in c
Groups Group I Group II
Total cholesterol (mg/dl) 43.70 ± 1.53b 44.52 ± 1.46b
Triglycerides (mg/dl) 40.75 ± 1.72b 45.43 ± 1.59b
LDL-C (mg/dl) 11.48 ± 3.29b 8.80 ± 3.24b
HDL-C (mg/dl) 28.10 ± 1.92a 27.58 ± 2.47a
VLDL-C (mg/dl) 8.15 ± 0.34b 9.09 ± 0.32b
Data expressed as mean ± SE
a,bThe groups in the same raw with different letters are statistically significant (*P <the adventitia, and the aortic tunica intima was irregular.
In addition, smooth muscle cells with a perinuclear halo
were seen in the tunica media. In contrast, BSEPS-
treated STZ rats did not show any appreciable change in
the heart (Fig. 6f ). Normal small intramyocardial arteries
were seen in the single-cell layer endothelium. No obvi-
ous damages of the aorta were observed in the BSEPS-
treated group IV (Fig. 6g).
Discussion
The understanding of cardiac abnormalities that accom-
pany diabetes is of high clinical relevance because, curi-
ously, diabetes increases the risk of coronary -artery
disease [51]. Hydroxyl radicals are the most reactive of
all the reduced forms of dioxygen and are believed to
initiate cell damage both in vitro and in vivo [52]. Gille
et al. [53] conclude that STZ-mediated hydroxyl radicals
and the generation of reactive oxygen species may be
crucial effectors in β-cell damage. Our data show a sig-
nificant decrease in the concentration of DPPH radicals
owing to the scavenging ability of BSEPS.
Our study investigated the effect of EPS treatment on
the lipid profile and cardiovascular disease risk predictor
(AI and CRI) in STZ-induced diabetic rats. Generally,
increase blood glucose levels characterize STZ-induced
diabetes, consistent with our results. Previously, STZ
diabetic animals were shown to exhibit tissue injury and
diabetic complications that involve the cardiovascular,
gastrointestinal, and nervous systems as well as the vas
deferens, kidney, eyes, and urinary bladder through in-
creased lipid peroxidation and oxidative stress [54]. Our
results indicate that diabetes induced a significant eleva-
tion of troponin levels. Diabetes triggers ongoing myo-
cardial damage, which manifests as elevated serumontrol, and STZ-induced diabetic rats
Group III Group IV F P-value
101.93 ± 7.38a 48.20 ± 2.46b 45.86* 0.000
130.82 ± 3.23a 47.22 ± 2.73b 309.01* 0.000
64.33 ± 7.26a 7.27 ± 1.91b 38.54* 0.000
11.43 ± 0.51b 32.21 ± 1.46a 29.29* 0.000
26.16 ± 0.65a 9.44 ± 0.55b 309.01* 0.000
0.05) using one-way ANOVA followed by Duncan as a post-hoc test
Table 3 Effect of treatment with polysaccharide on serum concentration of ICAM and VCAM in control, and STZ-induced diabetic
rats
Groups Group I Group II Group III Group IV F P-value
AI (mg/dl) 0.59 ± 0.17b 0.68 ± 0.2b 7.73 ± 0.59a 0.51 ± 0.08b 112.97* 0.000
CRI (mg/dl) 1.60 ± 0.19b 1.58 ± 0.20b 8.90 ± 0.56a 1.51 ± 0.09b 128.204* 0.000
ICAM (ng/ml) 6.03 ± 0.12c 5.21 ± 0.13d 7.96 ± 0.25a 6.89 ± 0.17b 42.00* 0.000
VCAM (ng/ml) 16.82 ± 1.34b 17.35 ± 0.69b 23.98 ± 0.45a 18.34 ± 0.99b 27.90* 0.000
Data expressed as mean ± SE
a,b,c,dThe groups in the same raw with different letters are statistically significant (*P < 0.05) using one-way ANOVA followed by Duncan as a post-hoc test
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events in patients with chronic heart failure [55, 56].
Our data indicate that BSEPS accentuates hyperlipid-
emia as efficiently as other polysaccharides [56]. BSEPS
protects against increases in glucose and decreases in in-
sulin that might be attributed to its ability to reduce
hyperglycemia. This might be via the inhibition of hep-
atic gluconeogenesis and glucose production from the
liver, which is accompanied by suppression of lipolysis in
adipose [57]. The abnormal high level of serum lipids in
diabetes is mainly due to an increase in the mobilization
of free fatty acids from peripheral fat depots by lipolysis
[58]. Increased release of free fatty acids increases the
production of ketone bodies and triglyceride synthesis.
In the present investigation, triglycerides were increased
significantly in diabetic control rats. Insulin deficiency
depletes the activity level of lipoprotein lipase, thus lead-
ing to abnormal lipoprotein metabolism in diabetes and
resulting in hypertriglyceridemia [59].
A major reason for cardiovascular disease in diabetes is
the lipid abnormalities that accompany atherosclerosis.
Therefore, an ideal treatment for diabetes, in addition to
glycemic control, ought to facilitate production of healthy
lipid profiles [60]. The present results elucidated a signifi-
cant increase in serum total lipids, total cholesterol, trigly-
ceride, LDL-cholesterol, and VLDL-cholesterol levels in
STZ control rats and decreased HDL-cholesterol levels
compared with normal rats. These results are consistent
with those of other investigators [61]. Additionally, in-
creased levels of serum triglycerides could also contributeTable 4 Pharmacological Study Acute Toxicity (LD) Testing of
BSEPS








The LD50 value of BSEPS = 600 mg/kgto reduced clearance of triglycerides, secondary to de-
creased activity of lipoprotein lipase [62]. The high level of
LDL-cholesterol found in STZ rats may be attributed to
cholesterol-mediated down-regulation of LDL receptors
[63]. Reduction in HDL following STZ may be because of
the acceleration of apoA-I clearance from the plasma
owing to elevated cholesterol [63]. Moreover, diabetes
often presents with impaired carbohydrate metabolism,
and increased lipolysis causes accumulation of acetyl CoA.
Increased availability of acetyl CoA leads to synthesis of
cholesterol and causes hyperlipidemia [64]. Notably, in-
creased total cholesterol levels were restored in BSEPS-
treated diabetic rats. Insulin deficiency is associated with
hypercholesterolemia owing to metabolic abnormalities
[65]. For example, serum lipids are increased by lipolysis
as a result of insulin deficiency in diabetic rats [66]. Usu-
ally, insulin increases lipogenesis and decreases lipolysis
and ketogenesis. However, in the diabetic condition, insu-
lin deficiency reverses the above-mentioned role in lipid
metabolism. Triglycerides are neutral fats and a major en-
ergy reserve for the body stored as adipose tissue. In the
present investigation, triglycerides increased significantly
following STZ treatment. Diabetes increases lipolysis and
produces more free fatty acids. Increased free fatty acids
increases production of ketone bodies and triglyceride
synthesis. The increased level of triglycerides was main-
tained in diabetic rats following BSEPS treatment.
LDL plays a significant role in atherosclerosis and re-
lated diseases. In the present study, LDL levels increased
in STZ-induced diabetic rats. Importantly, LDL transports
cholesterol from the liver to peripheral tissues, and is
formed from VLDL-cholesterol. VLDL levels also in-
creased in the present study after STZ injection, denoting
increased production of LDL-cholesterol. The effective
control of glycemic imbalance will reduce the VLDL and
triglyceride levels [67]. HDL cholesterol plays a role in
preventing atherosclerosis by transporting cholesterol
from peripheral tissues to the liver for excretion. A de-
crease in HDL was observed in the present study, which
increases the chances of atherosclerosis. Restoration of the
HDL decrease in treated diabetic rats shows the potential
alleviating capacity of BSEPS. Increased serum total chol-
esterol and LDL levels are negatively correlated with HDL
levels [67]. An increase in HDL-cholesterol is associated
Fig. 6 Heart: (a). Group I There was no histopathological alteration and the normal histological structure of the myocardium H& E × 64. Aorta: (b)
Group I There was no histopathological alteration and the normal histological structure of the tunica intima, media and adventitia H& E × 64. c:
Group II There was no histopathological alteration as recorded in heart tissue H& E × 64. Aorta (d): Group II There was no histopathological alteration
as recorded H& E × 64. e: Group III, Focal haemorrhages were detected in the myocardium H& E × 64. Aorta (f): There was oedema in the adventitia
(group III) H& E × 64. g; Group IV, there was no histopathological alteration the normal histological structure of the myocardium H& E × 64. Aorta (h):
Group IV there was no histopathological alteration as recorded H& E × 64
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elevated levels of total cholesterol, especially LDL-
cholesterol [68]. The antihyperglycemic effect of BSEPS
and hence an improved diabetic state may lead to a reduc-
tion in VLDL levels, and consequently LDL levels.
The AI and CRI are also quite high in STZ-induced
diabetic rats. Elevated serum lipids often indicatecoronary heart disease. BSEPS treatment improved the
worst condition to its normal level as compared with
the STZ group, as shown through increased HDL-
cholesterol. Importantly, HDLs protect against or re-
verse atherosclerosis by their ability to serve as acceptor
particles for macrophage cholesterol efflux, prevention of
endothelial dysfunction, and maintenance of endothelial
Ghoneim et al. BMC Complementary and Alternative Medicine  (2016) 16:112 Page 11 of 12integrity [69]. Moreover, the increase in HDL cholesterol
is associated with a decrease in coronary risk [70].
The histological findings showed that cardiac struc-
tural organization was disturbed in STZ-induced dia-
betic rats. Inflammatory histological change in cardiac
tissue indicates myocardial injury. Previous studies re-
ported diabetic cardiomyopathy as characterized by sys-
tolic or diastolic dysfunction and cardiac fibrosis in
diabetes patients [71]. In a state of insulin deficiency
(type 1 diabetes), there is a decrease in protein synthesis,
an increase in protein degradation, and defective mito-
chondrial function with loss of myofibrils in the heart
muscle [72, 73], which may disrupt the cardiac myo-fi-
bers. Aortic wall histology of diabetic rats indicated an
increase in thickness. In summary, our findings suggest
BSEPS extract provides a protective role for atheroscler-
osis in STZ-induced diabetic rats.
Conclusion
It is concluded that the BSEPS from Bacillus subtilus sp.
Suppress is effective in the management of the hypergly-
cemias as well as dyslipidemia in induced conditions like
diabetes. Treatment with BSEPS maintained the histo-
logical integrity of the cardiac tissues by reducing the
degenerative changes in the myocardium as well as in
the aortic tissues by decreasing the thickness of tunica
media. Also free radical scavenging activity also in-
creased with increasing concentration in the range of
30–100 μg/mL. These in-vitro assays of antioxidant indi-
cate that this BSEPS is a significant source of natural
antioxidant, which might be helpful in preventing the
progress of various oxidative stresses.
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